Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells
- PMID: 122990
Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells
Abstract
Mastocytoma cells (P815 of the DBA/2 strain) treated with increasing concentrations of glutaraldehyde were concurrently evaluated for their ability to incorporate exogeneous uridine, thymidine, and amino acids. The antigenic expression and membrane integrity of these treated cells were assayed by measuring their susceptibility to lysis by antibody and complement and by T-effector cells. The concentrations of glutarladehyde required to effect target cell antigen display were greater than those required to inhibit totally the cell's protein and nucleic acid synthetic processes. Thus, P815 cells treated with 0.15% glutaraldehyde for 10 sec were unable to incorporate either amino acids or nucleotides into macromolecules, but were readily lysed by effector T cell populations, and by alloantibody in the presence of complement. Target cells treated with glutaraldehyde concentrations in excess of 0.25% for 10 sec were resistant to both forms of immune lysis. In keeping with these observations, monolayers of P815 cells treated for 10 sec with 0.15% glutaraldehyde, were capable of specifically depleting T-effector cells from a cytolytically-active spleen cell population. After treatment with higher concentrations of glutaraldehyde (0.3%), however, the monolayers lost their capacity to adsorb effector cells. Although P815 cells treated with glutaraldehyde continued to exhibit H-2d alloantigen, neither these cells nor glutaraldehyde-treated DBA/2 spleen cells induced significant blastogenesis or stimulated the production of cytolytically active effector cells in mixed leukocyte cultures.
Similar articles
-
Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.J Immunol. 1975 Mar;114(3):1089-93. J Immunol. 1975. PMID: 163281
-
T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.J Immunol. 1977 May;118(5):1755-62. J Immunol. 1977. PMID: 404357
-
Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.J Immunol. 1975 Dec;115(6):1592-8. J Immunol. 1975. PMID: 810513
-
Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysis.J Immunol. 1976 Oct;117(4):1336-9. J Immunol. 1976. PMID: 135809
-
Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers.Eur J Immunol. 1972 Aug;2(4):380-3. doi: 10.1002/eji.1830020418. Eur J Immunol. 1972. PMID: 4628413 No abstract available.
Cited by
-
Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processing.J Exp Med. 1980 Feb 1;151(2):314-27. doi: 10.1084/jem.151.2.314. J Exp Med. 1980. PMID: 6766175 Free PMC article.
-
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.J Exp Med. 1983 Aug 1;158(2):303-16. doi: 10.1084/jem.158.2.303. J Exp Med. 1983. PMID: 6193218 Free PMC article.
-
Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.Br J Cancer. 1981 Apr;43(4):554-7. doi: 10.1038/bjc.1981.81. Br J Cancer. 1981. PMID: 6786316 Free PMC article. No abstract available.
-
Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.J Exp Med. 1982 Aug 1;156(2):492-505. doi: 10.1084/jem.156.2.492. J Exp Med. 1982. PMID: 6178787 Free PMC article.
-
Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.J Exp Med. 1986 Jul 1;164(1):211-26. doi: 10.1084/jem.164.1.211. J Exp Med. 1986. PMID: 2425028 Free PMC article.